Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Peripheral Blood Stem Cell Transplantation × Clear all

Sponsor

Conditions

Multiple Myeloma 46 Hodgkin Disease 43 Leukemia, Myeloid, Acute 41 Lymphoma, Non-Hodgkin 40 Leukemia, Lymphocytic, Chronic, B-Cell 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 35 Myelodysplastic Syndromes 33 Lymphoma, Mantle-Cell 33 Lymphoma, Large B-Cell, Diffuse 31 Lymphoma, Follicular 28 Leukemia 27 Burkitt Lymphoma 26 Lymphoma 25 Myeloproliferative Disorders 24 Lymphoma, Large-Cell, Immunoblastic 23 Congenital Abnormalities 23 Lymphoma, B-Cell, Marginal Zone 22 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myeloid, Accelerated Phase 20 Waldenstrom Macroglobulinemia 19 Blast Crisis 18 Lymphoma, T-Cell, Cutaneous 16 Lymphoma, Large-Cell, Anaplastic 16 Recurrence 14 Primary Myelofibrosis 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Neoplasms, Plasma Cell 14 Sezary Syndrome 12 Myelodysplastic-Myeloproliferative Diseases 12

Interventions

Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Valganciclovir 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡